Yoon Hang Kim MD

Board certified preventive medicine physician. University of Arizona fellowship grad. 20+ years prescribing LDN for chronic pain, autoimmune conditions & complex cases. Author. International speaker. Helping patients find answers.

When Food Becomes Opioid:How Casein- and Gluten-Derived Exorphins May Blunt the Effectiveness of Low Dose Naltrexone

Yoon Hang "John" Kim, MD, MPH www.directintegrativecare.com Abstract Low dose naltrexone (LDN) is widely used in integrative medicine for autoimmune disease, chronic pain, fibromyalgia, inflammatory bowel disease, and select malignancies. Its therapeutic effect is generally attributed to a brief, transient blockade of opioid receptors that triggers

By Yoon Hang Kim MD

Integrative Oncology

Toward the Exceptional Cancer Patient - What Bernie Siegel, Viktor Frankl, Radical Remission, and How to Starve Cancer Have in Common — and Why It Matters for Optimal Outcomes

Yoon Hang “John” Kim, MD, MPH  |  www.directintegrativecare.com An Academic Perspective on Integrative Oncology Why This Synthesis Matters Patients facing a serious cancer diagnosis often arrive at a familiar crossroads. The conventional oncology team hands them a treatment plan — chemotherapy, radiation, surgery, increasingly immunotherapy and targeted agents — and the

By Yoon Hang Kim MD
The Honest Truth About Low-Dose Naltrexone A Clinician’s Framework for Patients, Providers, and the LDN Community

The Honest Truth About Low-Dose Naltrexone A Clinician’s Framework for Patients, Providers, and the LDN Community

Yoon Hang Kim MD Membership-Based Integrative & Functional Medicine · www.directintegrativecare.com The Honest Truth About Low-Dose Naltrexone A Clinician’s Framework for Patients, Providers, and the LDN Community Yoon Hang “John” Kim, MD · Direct Integrative Care After two decades caring for patients with chronic, multi-system illness — and after years

By Yoon Hang Kim MD
Cholangiocarcinoma -A Clinical Overview: Staging, Treatment Algorithm, and an Integrative Oncology Checklist

Integrative Oncology

Cholangiocarcinoma -A Clinical Overview: Staging, Treatment Algorithm, and an Integrative Oncology Checklist

Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the epithelial lining of the biliary tree. The disease is traditionally divided by anatomic origin into three subtypes: intrahepatic (iCCA, arising from small bile ducts within the liver), perihilar (pCCA, at the hepatic duct confluence), and distal (dCCA, within the extrahepatic bile

By Yoon Hang Kim MD
Natural Support for High Blood Sugar - What the Evidence Says About Supplements for Glycemic Control

Natural Support for High Blood Sugar - What the Evidence Says About Supplements for Glycemic Control

Yoon Hang (John) Kim, MD, MPH  |  Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician  | www.directintegrativecare.com Clinical Overview Elevated blood sugar — whether characterized as insulin resistance, prediabetes, or type 2 diabetes — is one of the most common metabolic problems seen in integrative primary care. Patients frequently inquire about

By Yoon Hang Kim MD
Ketotifen for Mast Cell Activation Syndrome - Evidence and Clinical Integration in Functional Medicine

MCAS

Ketotifen for Mast Cell Activation Syndrome - Evidence and Clinical Integration in Functional Medicine

Yoon Hang “John” Kim, MD, MPH Board-certified in Preventive Medicine and Integrative & Holistic Medicine  •  Direct Integrative Care Ketotifen is a dual-action second-generation H1 antihistamine and partial mast cell stabilizer that has been used for decades in allergology and is increasingly positioned in functional medicine as bridge therapy for mast

By Yoon Hang Kim MD

Functional Medicine

The Metabolic-Hormonal Model of Weight Loss:Insulin, Ketosis, and the Clinical Frameworks of Westman, Fung, and Bikman

FUNCTIONAL MEDICINE PERSPECTIVE By Yoon Hang “John” Kim, MD, MPH Board-Certified in Preventive Medicine and Integrative/Holistic Medicine Yoon Hang Kim MD|  directintegrativecare.com KEY CLINICAL POINTS •  Obesity is reframed as a hormonal disorder driven by chronic hyperinsulinemia, not simply an energy-balance problem. •  Three complementary clinical frameworks — Westman (therapeutic carbohydrate

By Yoon Hang Kim MD